Copyright Reports & Markets. All rights reserved.

Global Preclinical In-vivo Imaging Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Preclinical In-vivo Imaging Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Optical Imaging Systems
    • 1.2.3 Micro-Ultrasound Systems
    • 1.2.4 Preclinical Nuclear Imaging Systems
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Preclinical In-vivo Imaging Market Share by Application: 2020 VS 2026
    • 1.3.2 Research & Development
    • 1.3.3 Drug Discovery
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Preclinical In-vivo Imaging Market Perspective (2015-2026)
  • 2.2 Global Preclinical In-vivo Imaging Growth Trends by Regions
    • 2.2.1 Preclinical In-vivo Imaging Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Preclinical In-vivo Imaging Historic Market Share by Regions (2015-2020)
    • 2.2.3 Preclinical In-vivo Imaging Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Preclinical In-vivo Imaging Players by Market Size
    • 3.1.1 Global Top Preclinical In-vivo Imaging Players by Revenue (2015-2020)
    • 3.1.2 Global Preclinical In-vivo Imaging Revenue Market Share by Players (2015-2020)
  • 3.2 Global Preclinical In-vivo Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Preclinical In-vivo Imaging Revenue
  • 3.4 Global Preclinical In-vivo Imaging Market Concentration Ratio
    • 3.4.1 Global Preclinical In-vivo Imaging Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Preclinical In-vivo Imaging Revenue in 2019
  • 3.5 Key Players Preclinical In-vivo Imaging Area Served
  • 3.6 Key Players Preclinical In-vivo Imaging Product Solution and Service
  • 3.7 Date of Enter into Preclinical In-vivo Imaging Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical In-vivo Imaging Breakdown Data by Type (2015-2026)

  • 4.1 Global Preclinical In-vivo Imaging Historic Market Size by Type (2015-2020)
  • 4.2 Global Preclinical In-vivo Imaging Forecasted Market Size by Type (2021-2026)

5 Preclinical In-vivo Imaging Breakdown Data by Application (2015-2026)

  • 5.1 Global Preclinical In-vivo Imaging Historic Market Size by Application (2015-2020)
  • 5.2 Global Preclinical In-vivo Imaging Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Preclinical In-vivo Imaging Market Size (2015-2026)
  • 6.2 North America Preclinical In-vivo Imaging Market Size by Type (2015-2020)
  • 6.3 North America Preclinical In-vivo Imaging Market Size by Application (2015-2020)
  • 6.4 North America Preclinical In-vivo Imaging Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Preclinical In-vivo Imaging Market Size (2015-2026)
  • 7.2 Europe Preclinical In-vivo Imaging Market Size by Type (2015-2020)
  • 7.3 Europe Preclinical In-vivo Imaging Market Size by Application (2015-2020)
  • 7.4 Europe Preclinical In-vivo Imaging Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Preclinical In-vivo Imaging Market Size (2015-2026)
  • 8.2 China Preclinical In-vivo Imaging Market Size by Type (2015-2020)
  • 8.3 China Preclinical In-vivo Imaging Market Size by Application (2015-2020)
  • 8.4 China Preclinical In-vivo Imaging Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Preclinical In-vivo Imaging Market Size (2015-2026)
  • 9.2 Japan Preclinical In-vivo Imaging Market Size by Type (2015-2020)
  • 9.3 Japan Preclinical In-vivo Imaging Market Size by Application (2015-2020)
  • 9.4 Japan Preclinical In-vivo Imaging Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Preclinical In-vivo Imaging Market Size (2015-2026)
  • 10.2 Southeast Asia Preclinical In-vivo Imaging Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Preclinical In-vivo Imaging Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Preclinical In-vivo Imaging Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Bruker
    • 11.1.1 Bruker Company Details
    • 11.1.2 Bruker Business Overview
    • 11.1.3 Bruker Preclinical In-vivo Imaging Introduction
    • 11.1.4 Bruker Revenue in Preclinical In-vivo Imaging Business (2015-2020))
    • 11.1.5 Bruker Recent Development
  • 11.2 Siemens
    • 11.2.1 Siemens Company Details
    • 11.2.2 Siemens Business Overview
    • 11.2.3 Siemens Preclinical In-vivo Imaging Introduction
    • 11.2.4 Siemens Revenue in Preclinical In-vivo Imaging Business (2015-2020)
    • 11.2.5 Siemens Recent Development
  • 11.3 TriFoil Imaging
    • 11.3.1 TriFoil Imaging Company Details
    • 11.3.2 TriFoil Imaging Business Overview
    • 11.3.3 TriFoil Imaging Preclinical In-vivo Imaging Introduction
    • 11.3.4 TriFoil Imaging Revenue in Preclinical In-vivo Imaging Business (2015-2020)
    • 11.3.5 TriFoil Imaging Recent Development
  • 11.4 PerkinElmer
    • 11.4.1 PerkinElmer Company Details
    • 11.4.2 PerkinElmer Business Overview
    • 11.4.3 PerkinElmer Preclinical In-vivo Imaging Introduction
    • 11.4.4 PerkinElmer Revenue in Preclinical In-vivo Imaging Business (2015-2020)
    • 11.4.5 PerkinElmer Recent Development
  • 11.5 Fujifilm VisualSonics
    • 11.5.1 Fujifilm VisualSonics Company Details
    • 11.5.2 Fujifilm VisualSonics Business Overview
    • 11.5.3 Fujifilm VisualSonics Preclinical In-vivo Imaging Introduction
    • 11.5.4 Fujifilm VisualSonics Revenue in Preclinical In-vivo Imaging Business (2015-2020)
    • 11.5.5 Fujifilm VisualSonics Recent Development
  • 11.6 MILabs
    • 11.6.1 MILabs Company Details
    • 11.6.2 MILabs Business Overview
    • 11.6.3 MILabs Preclinical In-vivo Imaging Introduction
    • 11.6.4 MILabs Revenue in Preclinical In-vivo Imaging Business (2015-2020)
    • 11.6.5 MILabs Recent Development
  • 11.7 Mediso
    • 11.7.1 Mediso Company Details
    • 11.7.2 Mediso Business Overview
    • 11.7.3 Mediso Preclinical In-vivo Imaging Introduction
    • 11.7.4 Mediso Revenue in Preclinical In-vivo Imaging Business (2015-2020)
    • 11.7.5 Mediso Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Preclinical In-vivo Imaging market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical In-vivo Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Optical Imaging Systems
    Micro-Ultrasound Systems
    Preclinical Nuclear Imaging Systems
    Other

    Market segment by Application, split into
    Research & Development
    Drug Discovery

    Based on regional and country-level analysis, the Preclinical In-vivo Imaging market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Preclinical In-vivo Imaging market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Bruker
    Siemens
    TriFoil Imaging
    PerkinElmer
    Fujifilm VisualSonics
    MILabs
    Mediso
    Buy now